Lista de obras -

ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation

artículo científico publicado en 2020

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience

artículo científico publicado en 2018

Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors

artículo científico publicado en 2016

Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B

scientific article published on 27 February 2019

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients"

artículo científico publicado en 2018

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk

scientific article published on 19 November 2018

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

scientific article published on 04 August 2019

Delayed Diagnosis and Disparity in Hepatitis C Virus-Infected Immigrants in North America: A Call for Action

artículo científico publicado en 2020

Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD

scientific article published on 19 December 2020

Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention

scientific article published on 16 August 2018

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.

artículo científico publicado en 2018

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply

artículo científico publicado en 2020

Editorial: comorbidities in patients with chronic hepatitis B-authors' reply

scientific article published on 01 September 2020

Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Authors' reply.

artículo científico publicado en 2017

Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply.

artículo científico publicado en 2018

Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a

scientific article published on 01 June 2018

Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes

scientific article published on 13 August 2020

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.

artículo científico publicado en 2017

Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016

scientific article published on 04 March 2020

Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients

scientific article published on 22 February 2020

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers

artículo científico publicado en 2020

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

scientific article published on 04 December 2020

High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b

artículo científico publicado en 2020

Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999–2018

artículo científico publicado en 2024

Increased mortality of patients with alcohol‐related liver diseases during the COVID‐19 pandemic in the United States

artículo científico publicado en 2022

Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B

artículo científico publicado en 2020

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population-authors' reply

artículo científico publicado en 2020

Letter: hepatic steatosis and fibrosis in chronic hepatitis B—the chicken‐and‐egg conundrum. Authors' reply

artículo científico publicado en 2021

Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally

scientific article published on 01 November 2020

Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic

scientific article published on 03 August 2020

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

artículo científico publicado en 2017

Non-alcoholic fatty liver disease (NAFLD) in Asia - More efforts are needed

artículo científico publicado en 2020

Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD)

artículo científico publicado en 2020

Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication

artículo científico publicado en 2019

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar

artículo científico publicado en 2017

Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.

artículo científico publicado en 2017

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors

scientific article published on 11 December 2020

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.

artículo científico publicado en 2017

Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population

scientific article published on 01 February 2020

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016

artículo científico publicado en 2020

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis

artículo científico publicado en 2017

Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States-a call for action

artículo científico publicado en 2020

Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

scientific article published on 22 August 2018

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

artículo científico publicado en 2018

Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.

artículo científico publicado en 2017

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir

artículo científico publicado en 2018

Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.

artículo científico publicado en 2018

Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.

artículo científico publicado en 2017

Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.

artículo científico publicado en 2018

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

scientific article published on 16 September 2019

Lista de obras de

ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience

Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors

Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients"

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk

Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

Delayed Diagnosis and Disparity in Hepatitis C Virus-Infected Immigrants in North America: A Call for Action

Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD

Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply

Editorial: comorbidities in patients with chronic hepatitis B-authors' reply

Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Authors' reply.

Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply.

Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a

Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.

Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016

Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b

Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999–2018

Increased mortality of patients with alcohol‐related liver diseases during the COVID‐19 pandemic in the United States

Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population-authors' reply

Letter: hepatic steatosis and fibrosis in chronic hepatitis B—the chicken‐and‐egg conundrum. Authors' reply

Letter: substantial under-diagnosis of NAFLD - more efforts are needed globally

Liver Care and Surveillance: The Global Impact of the COVID-19 Pandemic

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

Non-alcoholic fatty liver disease (NAFLD) in Asia - More efforts are needed

Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD)

Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar

Poor adherence to hepatocellular carcinoma surveillance: a systematic review and meta-analysis of a complex issue.

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.

Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis

Review article: current gaps and opportunities in HBV prevention, testing and linkage to care in the United States-a call for action

Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B

Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir

Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.

Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.

Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis